Surgery Doctors in Falmouth, ME Accepting Medicare

1 Surgery doctors found. Showing 1 - 1

Allen Finney Browne, M.D. Surgery - Pediatric Surgery Medicare: Not Enrolled in Medicare Practice Location: 25 Andrews Ave, Falmouth, ME 04105 Phone: 773-332-6789

News Archive

U.S. ambassador to U.N. food agencies, Ertharin Cousin, appointed to head WFP

Secretary-General Ban Ki-moon and U.N. Food and Agriculture Organization Director-General Jose Graziano da Silva on Tuesday announced the appointment of Ertharin Cousin, the U.S. ambassador to the U.N.'s Rome-based food agencies, to head the U.N. World Food Programme, the Associated Press/CBS News reports.

Study reports 9,500 injuries, 100 deaths related to crib products in the U.S.

Parents and caregivers have traditionally relied on cribs, playpens and bassinets to protect children while they sleep. The massive crib recalls followed by the announcement in December 2010 by the United States Consumer Product Safety Commission to ban drop-side cribs have caused many families to question the safety of these products.

AMA backs latest Senate bill

Senate Democrats were bolstered Monday by the endorsement of the American Medical Association as they push for a final vote this week on their health overhaul legislation, Bloomberg reports. "The bill advances many of our priority issues for achieving the vision of a health system that works for patients and physicians," the AMA's president-elect, Dr. Cecil Wilson, said in endorsing the most recent version of the Senate bill, proposed over the weekend by Senate Majority Leader Harry Reid, D-Nev. (Salant and Donmoyer, 12/22).

Genotoxic bacteria in the digestive tract

Escherichia coli is a commensal bacterium, which lives peacefully in our digestive tract. However, certain strains are pathogenic and are frequently incriminated in a broad spectrum of infections, affecting both farmed animals and humans (diarrhoea, urinary tract infections, food poisoning, septicaemia, neonatal meningitis, etc.).

SurModics licenses biodegradable polymer implant technology to Clinuvel

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it has entered into a license agreement with Clinuvel Pharmaceuticals Limited of Melbourne, Australia. Under the agreement, the Company's SurModics Pharmaceuticals unit has licensed certain of its biodegradable polymer implant technology to Clinuvel for the treatment of sun-induced skin disorders. Terms of the agreement were not disclosed.

Read more Medical News

› Verified 3 days ago